PBYI

FDA_logo

4 Top FDA Decisions Expected in Q1

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount to a great amount of risk ...
Read Full Story »
buy sell stocks

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Stocks have become quite choppy going into the end of 2015, and the strength of the bull market's nearly seven-year tenure is now up for question. Still, despite Wall Street ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: Coach, DuPont, GoPro, Match, Puma Bio, Square, Tesla and Many More

Stocks were indicated for a lower open on Monday, following oil south. While last week was painful, and while the six-year bull market has stalled at the end of 2015, ...
Read Full Story »
clinical trials

7 BioHealth Movers That Cannot Be Ignored

Over the past week, a few biotech companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

Stocks bounced big on Wednesday, but unlike Tuesday, the rally held and gained strength throughout the day. Stocks were green on Thursday morning too. This trend of buying the pullbacks, ...
Read Full Story »
generic drugs

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Typically when we cover index rebalancing or reconstitutions, they are happening within a few days of when our story is posted. Investors may have a huge head start as, even ...
Read Full Story »
95992888

9 Big Stocks That Doubled in 2014

The S&P 500 index has gained just over 12% in the past 52-weeks, a good effort, but far below the 32% return in 2013 and not quite up there with ...
Read Full Story »
95992888

Is Puma Biotech For Real, Again?

Puma Biotechnology Inc. (NYSE: PBYI) has just defied all odds in biotech. The stock has risen more than 200% in a single day, and its market cap magically jumped from ...
Read Full Story »
DNA

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

Binary events are often the key element in moving a biotech or health care stock higher. Negative binary results or actions often can move shares drastically lower. We scan our ...
Read Full Story »
DNA

UBS Top Stocks to Buy Working for Cancer Cures

Cancer is the leading cause of death globally, and a disease that touches almost every person in our nation one way or another. In a new research report, the Healthcare ...
Read Full Story »
Pills

Teva Acquisition Machine Gears Up: Who Is the Next Target?

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares recently hit a 52-week high after the chief financial officer of the maker of generic medicines said at a conference the company intends ...
Read Full Story »
Pills

UBS Has Nine Biotech Buyout and Merger Candidates

After three years of solid outperformance, most firms on Wall Street that we cover remain very positive on biotechnology as a whole. The analysts at UBS are not only bullish ...
Read Full Story »
Best DJIA stocks Q2 2013

The 10 Stocks With the Biggest Gains This Year

With the end of the year two weeks away, 10 stocks have already had gains of more than 400%. Investors in these stocks have been, if they held them for the ...
Read Full Story »
biotech

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report ...
Read Full Story »